查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1865430

全球真菌生物防治市场：预测至2032年－依产品类型、配方、作用机制、应用及地区分類的分析

Fungal Disease Biocontrol Market Forecasts to 2032 - Global Analysis By Product Type, Formulation, Mode of Action (Competition, Parasitism & Predation, Antibiosis, and Induced Systemic Resistance ), Application, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球真菌生物防治市场价值将达到 13 亿美元，到 2032 年将达到 40 亿美元。

预计在预测期内，生物防治市场将以16.6%的复合年增长率成长。真菌病害的生物防治是指策略性地利用生物体（主要是有益真菌、细菌或天然拮抗剂）来抑製或消除影响植物、动物和生态系统的致病真菌。这种环境永续的方法透过竞争排斥、寄生或诱导抗性来降低病害发生率，而无需依赖化学杀菌剂。生物防治剂的选择是基于其特异性、有效性和对生态系统影响的最小性，使其成为综合虫害管理（IPM）和农业长期韧性的重要组成部分。

根据联合国粮食及农业组织（粮农组织）的数据，每年全球高达 40% 的农作物产量因病虫害而损失，造成超过 2,200 亿美元的损失。

有机和永续农业的发展趋势

随着监管机构和消费者越来越支持环境友善作物保护方法，生物防治剂的需求正在蓬勃发展。这些解决方案能够减少化学残留，改善土壤健康，并符合有机认证标准。此外，政府补贴和支持永续投入的宣传宣传活动也进一步推动了生物防治剂的普及。预计这一趋势将在预测期内持续增强市场成长动能。

与化学农药相比，起效较慢

这种延迟起效在高压病害环境下可能是个显着的缺点，因为在这些环境下，快速介入至关重要。此外，由于环境差异导致的田间药效差异也会阻碍大规模种植者采用此产品。虽然目前正在进行研究以提高製剂稳定性和起效速度，但延迟起效已被认为是影响市场渗透的主要阻碍因素，尤其是在集约化农业系统发达的地区。

多功能产品的开发

多功能製剂结合了拮抗、竞争和诱导抗性等多种作用机制，可提供更全面的保护并提高可靠性。此外，多功能製剂还能降低病原体产生抗药性的风险，并更适用于综合虫害管理（IPM）方案。随着研究机构和生物技术公司对新型菌株和协同製剂技术的投资，市场有望受益于能够满足多样化作物保护需求的差异化产品。

来自新型化学杀菌剂的竞争

真菌病害生物防治市场面临新一代化学杀菌剂的竞争压力，这些化学杀菌剂具有起效迅速、广谱高效和保质期长等优点。这些合成替代品通常采用先进的施用系统且施用成本低廉，因此对传统种植者极具吸引力。此外，农业化学品生产商积极的营销和分销网络可能会掩盖生物防治方案的影响力。除非生物製剂展现出与之相当的性能和扩充性，否则化学创新带来的威胁可能会阻碍市场成长，尤其是在监管较为宽鬆的地区。

新冠疫情的影响：

新冠疫情扰乱了供应链，延误了田间试验，并暂时减缓了真菌生物防治剂的应用。然而，这场危机也带来了契机，促使人们更加关注永续粮食生产，并减少对化学物质的依赖。封锁和劳动力短缺迫使农民寻求更具韧性、投入更少的解决方案，间接推动了生物防治剂的应用。此外，疫情后农业生物技术投入的增加以及对粮食安全的重新关注，为市场的长期復苏创造了有利条件。

预计在预测期内，微生物学领域将占据最大的市场份额。

由于微生物製剂已被证实具有显着功效，且适用于多种作物，预计在预测期内，微生物製剂将占据最大的市场份额。木霉属、芽孢桿菌属和假单胞菌属等微生物製剂因其拮抗特性和与有机农业的兼容性而被广泛应用。它们能够定殖于植物根系并透过多种机制抑制病原体，因此深受种植者的青睐。此外，製剂技术的进步和监管核准的获批进一步增强了商业性可行性，巩固了其市场主导地位。

预计在预测期内，诱导系统性阻力（ISR）板块的复合年增长率将最高。

预计在预测期内，诱导系统抗性（ISR）领域将实现最高成长率，这主要得益于其增强植物对多种真菌病原体免疫力的能力。基于ISR的生物防治剂能够活化植物的内部防御机制，提供持久的保护，而无需直接针对病原体。这种作用机转在综合虫害管理系统中尤其重要。此外，ISR产品在高价值园艺作物中也越来越受欢迎，因为在这些作物中，零残留解决方案至关重要，这也有助于其加速推广应用并提高复合年增长率。

占比最大的地区：

预计在预测期内，欧洲地区将占据最大的市场份额，这主要得益于鼓励生物防治剂使用的严格法规结构以及有机农业的广泛应用。法国、德国和荷兰等国积极透过补贴和研究倡议推广生物防治技术。此外，消费者对无残留产品的需求不断增长，以及对环境管理的日益重视，也推动了市场成长。主要生物防治剂生产商的存在以及合作研发项目进一步巩固了欧洲在真菌病害生物防治市场的主导地位。

预计复合年增长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于人们对永续农业的日益关注以及减少化学农药使用的压力不断增大。印度、中国和越南等新兴经济体由于政府主导的措施和有机农地的扩张，正迅速采用生物防治剂。此外，该地区多样化的气候条件和作物特性也催生了对客製化真菌生物防治解决方案的强劲需求。策略伙伴关係和在地化生产也促进了市场的加速成长。

免费客製化服务

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 原始研究资料
    • 二手研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球真菌病害生物防治市场（依产品类型划分）

  • 介绍
  • 微生物
    • 细菌
    • 真菌
    • 酵母菌
  • 植物成分和植物萃取物
  • 矿物

6. 全球真菌生物防治市场（依製剂划分）

  • 介绍
  • 湿剂型（液体）
    • 水溶液
    • 乳液
  • 干粉剂型
    • 可湿性粉
    • 颗粒

7. 全球真菌病害生物防治市场（依作用机制划分）

  • 介绍
  • 竞赛
  • 寄生/捕食
  • 抗生素
  • 诱导系统性抵抗（ISR）

8. 全球真菌病害生物防治市场（依应用领域划分）

  • 介绍
  • 农业
    • 水果和蔬菜
    • 粮食
    • 油籽/豆类
    • 其他作物
  • 园艺和室内植物
  • 草坪和造景管理
  • 收穫后用途

9. 全球真菌病害生物防治市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • BASF SE
  • Bayer AG
  • Syngenta AG
  • Corteva Agriscience, Inc.
  • FMC Corporation
  • UPL Limited
  • Valent Biosciences Corporation
  • Certis USA LLC
  • Koppert BV
  • Marrone Bio Innovations, Inc.
  • BIOWORKS, Inc.
  • Andermatt Biocontrol AG
  • Novozymes A/S
  • Isagro SpA
  • Nufarm Limited
Product Code: SMRC32193

According to Stratistics MRC, the Global Fungal Disease Biocontrol Market is accounted for $1.3 billion in 2025 and is expected to reach $4.0 billion by 2032, growing at a CAGR of 16.6% during the forecast period. Fungal disease biocontrol is the strategic use of living organism's primarily beneficial fungi, bacteria, or natural antagonists to suppress or eliminate pathogenic fungi affecting plants, animals, or ecosystems. This environmentally sustainable approach leverages competitive exclusion, parasitism, or induced resistance to reduce disease incidence without relying on chemical fungicides. Biocontrol agents are selected for their specificity, efficacy, and minimal ecological disruption, making them integral to integrated pest management and long-term agricultural resilience.

According to FAO, up to 40% of global crop production is lost to pests and diseases each year, costing over $220 billion.

Market Dynamics:

Driver:

Growing organic farming and sustainable agriculture trends

As regulatory bodies and consumers increasingly favor eco-friendly crop protection methods, demand for biological control agents has surged. These solutions offer reduced chemical residues and improved soil health, aligning with organic certification standards. Moreover, government subsidies and awareness campaigns supporting sustainable inputs have further accelerated adoption. This trend is expected to continue strengthening the market's growth trajectory throughout the forecast period.

Restraint:

Slower action compared to chemical alternatives

This delayed efficacy can be a critical drawback in high-pressure disease environments where rapid intervention is essential. Additionally, inconsistent field performance due to environmental variability may deter adoption among large-scale growers. While ongoing research aims to enhance formulation stability and speed of action, the perceived lag in results remains a significant restraint impacting market penetration, particularly in regions with intensive farming systems.

Opportunity:

Development of multi-mode action products

Multi-mode action formulations combine mechanisms such as antagonism, competition, and induced resistance, offering broader-spectrum protection and improved reliability. Furthermore, multi-functional agents reduce the risk of pathogen resistance and enhance compatibility with integrated pest management (IPM) programs. As research institutions and biotech firms invest in novel strains and synergistic blends, the market is poised to benefit from differentiated offerings that meet diverse crop protection needs.

Threat:

Competition from new chemical fungicides

The fungal disease biocontrol market faces competitive pressure from next-generation chemical fungicides that offer rapid action, broad-spectrum efficacy, and longer shelf life. These synthetic alternatives often come with advanced delivery systems and lower application costs, making them attractive to conventional growers. Moreover, aggressive marketing and distribution networks of agrochemical companies can overshadow biocontrol solutions. Unless biological agents demonstrate comparable performance and scalability, the threat from chemical innovations may hinder market growth, especially in regions with limited regulatory restrictions.

Covid-19 Impact:

The COVID-19 pandemic disrupted supply chains and delayed field trials, temporarily slowing the adoption of fungal biocontrol agents. However, the crisis also heightened awareness around sustainable food production and reduced chemical dependency. Lockdowns and labor shortages prompted growers to seek resilient, low-input solutions, indirectly supporting biocontrol uptake. Additionally, increased funding for agricultural biotechnology and renewed focus on food security post-pandemic have created favorable conditions for long-term market recovery.

The microbials segment is expected to be the largest during the forecast period

The microbials segment is expected to account for the largest market share during the forecast period due to its proven efficacy and wide applicability across crops. Microbial agents such as Trichoderma, Bacillus, and Pseudomonas species are extensively used for their antagonistic properties and compatibility with organic farming. Their ability to colonize plant roots and suppress pathogens through multiple mechanisms makes them a preferred choice among growers. Moreover, advancements in formulation technologies and regulatory approvals have further strengthened their commercial viability, solidifying their dominance in the market.

The induced systemic resistance (ISR) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the induced systemic resistance (ISR) segment is predicted to witness the highest growth rate driven by its ability to enhance plant immunity against a broad range of fungal pathogens. ISR-based biocontrol agents activate the plant's internal defense pathways, offering long-lasting protection without direct pathogen targeting. This mode of action is particularly valuable in integrated pest management systems. Furthermore, ISR products are gaining traction in high-value horticultural crops, where residue-free solutions are critical, contributing to their accelerated adoption and CAGR.

Region with largest share:

During the forecast period, the Europe region is expected to hold the largest market share propelled by stringent regulatory frameworks favoring biological inputs and widespread organic farming practices. Countries such as France, Germany, and the Netherlands have actively promoted biocontrol adoption through subsidies and research initiatives. Additionally, consumer demand for residue-free produce and environmental stewardship has driven market growth. The presence of key biocontrol manufacturers and collaborative R&D programs further reinforces Europe's leadership position in the fungal disease biocontrol landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising awareness of sustainable agriculture and increasing pressure to reduce chemical pesticide use. Emerging economies such as India, China, and Vietnam are witnessing rapid adoption of biocontrol agents due to government-led initiatives and expanding organic acreage. Moreover, the region's diverse climatic conditions and crop profiles create a robust demand for tailored fungal biocontrol solutions. Strategic partnerships and local manufacturing are also contributing to accelerated market growth.

Key players in the market

Some of the key players in Fungal Disease Biocontrol Market include BASF SE, Bayer AG, Syngenta AG, Corteva Agriscience, Inc., FMC Corporation, UPL Limited, Valent Biosciences Corporation, Certis USA L.L.C., Koppert B.V., Marrone Bio Innovations, Inc., BIOWORKS, Inc., Andermatt Biocontrol AG, Novozymes A/S, Isagro S.p.A., and Nufarm Limited.

Key Developments:

In September 2025, Syngenta partnered with Lavie Bio to develop novel biological insecticidal solutions, targeting sustainable insect and disease management, leveraging innovative bio-technology platforms.

In September 2025, Corteva introduced Zorvec Entecta, a fungicide protecting grapes and potatoes from Downy Mildew and Late Blight, featuring stable rain fastness and systemic mobility. The product supports growers with sustainable disease control.

In January 2025, UPL acquired Corteva's mancozeb business including the Dithane(R) fungicide, a trusted broad-spectrum fungicide effective against multiple fungal diseases with an improved Rainshield(TM) formulation for better disease control and environmental compliance.

Product Types Covered:

  • Microbials
  • Botanicals & Plant Extracts
  • Minerals

Formulations Covered:

  • Wet Formulations (Liquid)
  • Dry Formulations

Mode of Actions Covered:

  • Competition
  • Parasitism & Predation
  • Antibiosis
  • Induced Systemic Resistance (ISR)

Applications Covered:

  • Agriculture
  • Horticulture & Ornamentals
  • Turf & Landscape Management
  • Post-Harvest Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Fungal Disease Biocontrol Market, By Product Type

  • 5.1 Introduction
  • 5.2 Microbials
    • 5.2.1 Bacteria
    • 5.2.2 Fungi
    • 5.2.3 Yeasts
  • 5.3 Botanicals & Plant Extracts
  • 5.4 Minerals

6 Global Fungal Disease Biocontrol Market, By Formulation

  • 6.1 Introduction
  • 6.2 Wet Formulations (Liquid)
    • 6.2.1 Aqueous Solutions
    • 6.2.2 Emulsifiable Concentrates
  • 6.3 Dry Formulations
    • 6.3.1 Wettable Powders
    • 6.3.2 Granules

7 Global Fungal Disease Biocontrol Market, By Mode of Action

  • 7.1 Introduction
  • 7.2 Competition
  • 7.3 Parasitism & Predation
  • 7.4 Antibiosis
  • 7.5 Induced Systemic Resistance (ISR)

8 Global Fungal Disease Biocontrol Market, By Application

  • 8.1 Introduction
  • 8.2 Agriculture
    • 8.2.1 Fruits & Vegetables
    • 8.2.2 Cereals & Grains
    • 8.2.3 Oilseeds & Pulses
    • 8.2.4 Other Crops
  • 8.3 Horticulture & Ornamentals
  • 8.4 Turf & Landscape Management
  • 8.5 Post-Harvest Applications

9 Global Fungal Disease Biocontrol Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 BASF SE
  • 11.2 Bayer AG
  • 11.3 Syngenta AG
  • 11.4 Corteva Agriscience, Inc.
  • 11.5 FMC Corporation
  • 11.6 UPL Limited
  • 11.7 Valent Biosciences Corporation
  • 11.8 Certis USA L.L.C.
  • 11.9 Koppert B.V.
  • 11.10 Marrone Bio Innovations, Inc.
  • 11.11 BIOWORKS, Inc.
  • 11.12 Andermatt Biocontrol AG
  • 11.13 Novozymes A/S
  • 11.14 Isagro S.p.A.
  • 11.15 Nufarm Limited

List of Tables

  • Table 1 Global Fungal Disease Biocontrol Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Fungal Disease Biocontrol Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Fungal Disease Biocontrol Market Outlook, By Microbials (2024-2032) ($MN)
  • Table 4 Global Fungal Disease Biocontrol Market Outlook, By Bacteria (2024-2032) ($MN)
  • Table 5 Global Fungal Disease Biocontrol Market Outlook, By Fungi (2024-2032) ($MN)
  • Table 6 Global Fungal Disease Biocontrol Market Outlook, By Yeasts (2024-2032) ($MN)
  • Table 7 Global Fungal Disease Biocontrol Market Outlook, By Botanicals & Plant Extracts (2024-2032) ($MN)
  • Table 8 Global Fungal Disease Biocontrol Market Outlook, By Minerals (2024-2032) ($MN)
  • Table 9 Global Fungal Disease Biocontrol Market Outlook, By Formulation (2024-2032) ($MN)
  • Table 10 Global Fungal Disease Biocontrol Market Outlook, By Wet Formulations (Liquid) (2024-2032) ($MN)
  • Table 11 Global Fungal Disease Biocontrol Market Outlook, By Aqueous Solutions (2024-2032) ($MN)
  • Table 12 Global Fungal Disease Biocontrol Market Outlook, By Emulsifiable Concentrates (2024-2032) ($MN)
  • Table 13 Global Fungal Disease Biocontrol Market Outlook, By Dry Formulations (2024-2032) ($MN)
  • Table 14 Global Fungal Disease Biocontrol Market Outlook, By Wettable Powders (2024-2032) ($MN)
  • Table 15 Global Fungal Disease Biocontrol Market Outlook, By Granules (2024-2032) ($MN)
  • Table 16 Global Fungal Disease Biocontrol Market Outlook, By Mode of Action (2024-2032) ($MN)
  • Table 17 Global Fungal Disease Biocontrol Market Outlook, By Competition (2024-2032) ($MN)
  • Table 18 Global Fungal Disease Biocontrol Market Outlook, By Parasitism & Predation (2024-2032) ($MN)
  • Table 19 Global Fungal Disease Biocontrol Market Outlook, By Antibiosis (2024-2032) ($MN)
  • Table 20 Global Fungal Disease Biocontrol Market Outlook, By Induced Systemic Resistance (ISR) (2024-2032) ($MN)
  • Table 21 Global Fungal Disease Biocontrol Market Outlook, By Application (2024-2032) ($MN)
  • Table 22 Global Fungal Disease Biocontrol Market Outlook, By Agriculture (2024-2032) ($MN)
  • Table 23 Global Fungal Disease Biocontrol Market Outlook, By Fruits & Vegetables (2024-2032) ($MN)
  • Table 24 Global Fungal Disease Biocontrol Market Outlook, By Cereals & Grains (2024-2032) ($MN)
  • Table 25 Global Fungal Disease Biocontrol Market Outlook, By Oilseeds & Pulses (2024-2032) ($MN)
  • Table 26 Global Fungal Disease Biocontrol Market Outlook, By Other Crops (2024-2032) ($MN)
  • Table 27 Global Fungal Disease Biocontrol Market Outlook, By Horticulture & Ornamentals (2024-2032) ($MN)
  • Table 28 Global Fungal Disease Biocontrol Market Outlook, By Turf & Landscape Management (2024-2032) ($MN)
  • Table 29 Global Fungal Disease Biocontrol Market Outlook, By Post-Harvest Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.